Pathophysiology of RAGE in inflammatory diseases

H Dong, Y Zhang, Y Huang, H Deng - Frontiers in Immunology, 2022 - frontiersin.org
The receptor for advanced glycation end products (RAGE) is a non-specific multi-ligand
pattern recognition receptor capable of binding to a range of structurally diverse ligands …

Targeting RAGE signaling in inflammatory disease

BI Hudson, ME Lippman - Annual review of medicine, 2018 - annualreviews.org
The receptor for advanced glycation end-products (RAGE) is a multiligand pattern
recognition receptor implicated in diverse chronic inflammatory states. RAGE binds and …

Apoptosis, autophagy, necroptosis, and cancer metastasis

Z Su, Z Yang, Y Xu, Y Chen, Q Yu - Molecular cancer, 2015 - Springer
Metastasis is a crucial hallmark of cancer progression, which involves numerous factors
including the degradation of the extracellular matrix (ECM), the epithelial-to-mesenchymal …

All the “RAGE” in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses

EA Oczypok, TN Perkins, TD Oury - Paediatric respiratory reviews, 2017 - Elsevier
The receptor for advanced glycation endproducts (RAGE) is a pro-inflammatory pattern
recognition receptor (PRR) that has been implicated in the pathogenesis of numerous …

S100A8/A9 activate key genes and pathways in colon tumor progression

M Ichikawa, R Williams, L Wang, T Vogl… - Molecular cancer …, 2011 - AACR
The tumor microenvironment plays an important role in modulating tumor progression.
Earlier, we showed that S100A8/A9 proteins secreted by myeloid-derived suppressor cells …

Molecular characteristics of RAGE and advances in small-molecule inhibitors

HJ Kim, MS Jeong, SB Jang - International journal of molecular sciences, 2021 - mdpi.com
Receptor for advanced glycation end-products (RAGE) is a member of the immunoglobulin
superfamily. RAGE binds and mediates cellular responses to a range of DAMPs (damage …

Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis

T Kwak, K Drews-Elger, A Ergonul, PC Miller, A Braley… - Oncogene, 2017 - nature.com
The receptor for advanced glycation end products (RAGE) is highly expressed in various
cancers and is correlated with poorer outcome in breast and other cancers. Here we tested …

RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer

M Magna, GH Hwang, A McIntosh, K Drews-Elger… - NPJ Breast …, 2023 - nature.com
Triple-negative breast cancer (TNBC) is a highly aggressive and metastatic cancer subtype,
which is generally untreatable once it metastasizes. We hypothesized that interfering with …

RAGE expression in human T cells: a link between environmental factors and adaptive immune responses

EM Akirav, P Preston-Hurlburt, J Garyu, O Henegariu… - PloS one, 2012 - journals.plos.org
The Receptor for Advanced Glycation Endproducts (RAGE) is a scavenger ligand that binds
glycated endproducts as well as molecules released during cell death such as S100b and …

The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines

RC Chen, PP Yi, RR Zhou, MF Xiao, ZB Huang… - Molecular and cellular …, 2014 - Springer
High mobility group protein box1 (HMGB1) and its receptor—receptor for advanced
glycation end products (RAGE) are pivotal factors in the development and progression of …